Overview
By combining clinical expertise with research insight, we drive progress in prevention, early detection, and care, improving health outcomes in Saudi Arabia.
Local and Global Studies to Investigate Associations Between Risk Factors and Disease, as Well as to Evaluate Treatment Outcomes
Our research team is leading key projects to advance the understanding and management of liver and gastrointestinal diseases in the Kingdom. These include the liver cancer registry to collect comprehensive data on disease patterns, causes, and future prevention strategies. In addition, the team is studying fatty liver disease to assess its prevalence and identify lifestyle-related risk factors. We also lead a global initiative focused on liver diseases, examining risk factors, and improving patients’ quality of life. Furthermore, the team employs advanced artificial intelligence technologies to develop more accurate methods for the early detection of colorectal cancer, helping to increase opportunities for effective treatment and recovery.
Our Team
A multidisciplinary team working in a collaborative research environment.

Saleh Ali Alqahtani
Professor of Medicine / Group Leader

Saleh Alessy
Associate Scientist

Duna Barakah
Associate Scientist
Projects
- Hepatocellular Carcinoma Registry.
- Genomics and Environmental Noninvasive Evaluation for Saudi Intrahepatic Steatosis (GENESIS).
- The Global Liver Registry™.
- Development of Saudi Arabia’s First SAP-Based Organoid 3D Platform.
- Surveillance and Treatment of Primary Hepatocellular Carcinoma (STOP HCC).
- Early Detection and Diagnosis of Colorectal Cancer in Saudi Arabia (AI Colonoscopy).
Beta Version
Research services